Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558271PMC
http://dx.doi.org/10.1016/j.jdcr.2019.03.024DOI Listing

Publication Analysis

Top Keywords

palmoplantar pustulosis-like
4
pustulosis-like eruption
4
eruption tofacitinib
4
tofacitinib therapy
4
therapy juvenile
4
juvenile idiopathic
4
idiopathic arthritis
4
palmoplantar
1
eruption
1
tofacitinib
1

Similar Publications

Objectives: Baricitinib is an orally active Janus kinase (JAK) inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA).

Materials And Methods: Here, we report the case of a 56-year-old Caucasian male diagnosed with RA who developed palmoplantar pustulosis (PPP) while being treated with baricitinib.

Results: The patient's PPP resolved after discontinuation of baricitinib and recurred when this was restarted.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!